Skip Navigation

Amy L. Billett, MD

Pediatric Hematology/Oncology

Make an Appointment
Watch Video


  • Director of Safety and Quality, Division of Pediatric Hematology/Oncology
  • Institute Physician
  • Associate Professor of Pediatrics, Harvard Medical School

Clinical Interests

  • Electronic health records
  • Global health
  • Lymphoma (Hodgkin and Non-Hodgkin)
  • Management of nausea and vomiting
  • Patient safety
  • Quality improvement

Contact Information

  • Appointments888-733-4662 (new)
    617-632-3270 (established)
  • Office Phone Number617-632-5640
  • Fax617-632-4811


Dr. Billett received her MD from Harvard Medical School in 1984. After completing a residency in pediatrics at the University of Washington Hospitals, she completed a fellowship in pediatric hematology-oncology at Children's Hospital Boston and Dana-Farber Cancer Institute and became a staff physician in the pediatric hematology/oncology program in 1990. She was the medical director of the inpatient oncology service at Children's Hospital 1995-2005.

Dr. Billett has participated in multiple projects involving improving systems of care, including development of a pediatric chemotherapy order entry system, implementation of the joint CH-DFCI pediatric electronic health record. She is currently the medical director for patient safety and quality in the pediatric hematology/oncology program, the leader of the pediatric lymphoma program, and an active clinician in the program.

She is a clinical faculty leader of the newly established national collaborative to reduce catheter-associated blood stream infections in pediatric hematology/oncology patients.

Board Certification:

  • Pediatric Hematology/Oncology, 2001


  • Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology


  • University of Washington Hospitals

Medical School:

  • Harvard Medical School

Recent Awards:

  • Leadership Development for Physicians, Harvard Medical School, Boston, MA 2003


Hodgkin's Disease in Children, CLABSI-reduction

Our program has been an active member of a small national consortium for clinical trials in pediatric Hodgkins since 1990. pediatric Hodgkin's disease. We currently have three open trials looking at improving/maintaining efficacy while minimizing long-term toxicity.Our center is a founding member of a national quality improvement collaborative started in 2009 to reduce catheter-associated blood stream infections in pediatric hematology-oncology patients. The focus of the collaborative is reliable implementation of best central line maintenance care.

Research Departments:


Dana-Farber Cancer Institute
450 Brookline Avenue
Shields Warren 360
Boston, MA 02215
Get Directions